Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517993 | SCV000615166 | uncertain significance | not specified | 2016-09-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551603 | SCV000645239 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448560 | SCV002732420 | uncertain significance | Inborn genetic diseases | 2022-03-11 | criteria provided, single submitter | clinical testing | The c.2395C>T (p.H799Y) alteration is located in exon 10 (coding exon 8) of the SETX gene. This alteration results from a C to T substitution at nucleotide position 2395, causing the histidine (H) at amino acid position 799 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |